| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/26/2011 | CN101348471B Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 01/25/2011 | US7875621 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors |
| 01/25/2011 | US7875610 Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| 01/25/2011 | US7875604 Compounds that inhibit HIV particle formation |
| 01/25/2011 | US7875600 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 01/25/2011 | CA2483090C Use of therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions |
| 01/25/2011 | CA2458528C C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as medicaments |
| 01/25/2011 | CA2368849C Process for preparing amine platinum complexes |
| 01/20/2011 | WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/20/2011 | WO2011007090A1 Derivatives of 5,6-bisaryl-2-pyrimidine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
| 01/20/2011 | WO2010114292A3 Improved method for manufacturing dipeptidyl peptidase-iv inhibitor and intermediate |
| 01/20/2011 | US20110015204 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/20/2011 | US20110014299 Solid preparation comprising alogliptin and metformin hydrochloride |
| 01/20/2011 | CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 01/19/2011 | EP2275413A1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. |
| 01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
| 01/19/2011 | EP2274288A2 Macrocyclic compounds and their use as kinase inhibitors |
| 01/19/2011 | EP2150527B1 Anthranilic acid derivative as anticancer agent and a process for the preparation thereof |
| 01/19/2011 | EP2013179B1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/19/2011 | EP1067123B1 Nitrogenous heterocyclic compounds |
| 01/19/2011 | CN101952453A ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof |
| 01/19/2011 | CN101948441A Novel preparation method of Erlotinib hydrochloride with crystal form A |
| 01/19/2011 | CN101948440A Dye compound |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101948438A Novel method for preparing rosuvastatin calcium |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101948366A Method for preparing 4-(diphenylamino)biaryl compound in water phase |
| 01/18/2011 | US7872128 6-chloro-N-(pyrimidin-5-yl)-3-(3-(trifluoromethyl)phenylamino)benzo[d]isoxazole-7-carboxamide; autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases |
| 01/18/2011 | US7872127 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 01/18/2011 | US7872126 Tetrahydroquinoline derivatives and a process for preparing the same |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872124 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids |
| 01/18/2011 | US7872012 Pyrimidinone compounds and preparation and use thereof |
| 01/18/2011 | US7872010 Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors |
| 01/18/2011 | US7872000 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/13/2011 | WO2011005832A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl] -benzoylamino} -4-methylenξ-penta nedioic acid |
| 01/13/2011 | WO2011005645A1 Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl] |
| 01/13/2011 | WO2011004402A2 Improved process for the preparation of ambrisentan and novel intermediates thereof |
| 01/13/2011 | WO2011003528A2 Substituted phenyl(oxy/thio)alkanol derivatives |
| 01/13/2011 | WO2011003527A1 Phenyl(oxy/thio)alkanol derivatives |
| 01/13/2011 | WO2010128346A3 Rosuvastatin manganse, copper, iron and zinc salts with high photochemical stability |
| 01/13/2011 | WO2010012442A8 Insecticidal benzenedicarboxamide derivative |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009607 Method for preparing dna fragment having sticky end |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009427 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/13/2011 | US20110009421 Compound having 6-membered aromatic ring |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009371 Synthesis of tetracyclines and analogues thereof |
| 01/13/2011 | US20110009369 Anti-influenza compounds |
| 01/13/2011 | US20110008461 Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase |
| 01/13/2011 | US20110005947 Inhibitors of jak |
| 01/13/2011 | CA2775312A1 Substituted phenyl(oxy/thio)alkanol derivatives |
| 01/13/2011 | CA2767385A1 Phenyl(oxy/thio)alkanol derivatives |
| 01/13/2011 | CA2767257A1 Stable crystalline polymorphs of the dipotassium salt of (s)-2-{4-[2-(2,4-diamino-quinazolin-6-yl)-ethyl]-benzoylamino}-4-methylene-penta nedioic acid |
| 01/12/2011 | EP2272842A1 Process for the manufacture of the calcium salt of rosuvastatin and crystalline intermediates thereof |
| 01/12/2011 | EP2272833A1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
| 01/12/2011 | EP2271631A2 Inhibitors of protein kinases |
| 01/12/2011 | EP2271630A1 Compounds and compositions as protein kinase inhibitors |
| 01/12/2011 | EP2271629A1 Substituted pyrimidin-5-carboxamides 281 |
| 01/12/2011 | EP2271622A2 Heteroaryl derivatives as cftr modulators |
| 01/12/2011 | EP2271620A1 Compositions and methods for inhibition of hepatocyte growth factory receptor c-met signaling |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | EP1603888B1 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazoline-4-yl) acetic acids as anti-viral agents, especially against cytomegalo viruses |
| 01/12/2011 | CN1980898B Nucleoside derivatives and therapeutic uses therof |
| 01/12/2011 | CN101945652A Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase |
| 01/12/2011 | CN101941946A Disubstituted benzene uracil peptide nucleic acid monomer and intermediate as well preparation methods and applications thereof |
| 01/12/2011 | CN101941941A Carboxylic ester compound and applications thereof |
| 01/12/2011 | CN101941917A Amide compounds and use thereof |
| 01/12/2011 | CN101591301B Preparation method of 3, 5-dihydroxy heptyl-6-gadoleic acid derivative |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868169 t-butyl ester of (+)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methane-sulfonylaminopyrimidin)-5-yl)-3(R)hydroxy-5-oxo-(E)-6-heptenoic acid; crystalline forms may be easier to handle and process than oil intermediates; crystallization in methanol/H2O; heating, cooling, seeding, cooling, recovering |
| 01/11/2011 | US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 01/11/2011 | US7867629 2,4-Diphenyl-6-(10-phenyl-anthracen-9-yl-pyrimidine; achieves elevation of luminance; excellent efficiency of light emission; long lifetime by an improvement of an electrode adhesion; durability; stability; OLED/organic light emitters |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2468824C Hexacyclic compounds |
| 01/11/2011 | CA2461439C Novel .alpha.-oxygenated or .alpha.-thiolated carboxylic acid phenethylamide derivatives |
| 01/11/2011 | CA2456426C New mandelic acid derivatives and their use as thrombin inhibitors |
| 01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/10/2011 | CA2709624A1 Immediate release dosage form of bosentan and process of manufacturing such |
| 01/06/2011 | WO2011001114A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011001113A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | WO2010131118A3 Polymorphs of etravirine and processes for preparation thereof |
| 01/06/2011 | WO2010101863A3 Brush polymer coating by in situ polymerization from photoreactive surface |
| 01/06/2011 | US20110003992 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors |
| 01/06/2011 | US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/06/2011 | US20110003011 Fungicidal active compound combinations |
| 01/06/2011 | CA2767064A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | CA2766909A1 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |